417 related articles for article (PubMed ID: 23404859)
1. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
[TBL] [Abstract][Full Text] [Related]
2. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Boeri M; Pastorino U; Sozzi G
Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
[TBL] [Abstract][Full Text] [Related]
4. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
Gao W; Xu J; Shu YQ
Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239
[TBL] [Abstract][Full Text] [Related]
5. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
6. Isothermally sensitive detection of serum circulating miRNAs for lung cancer diagnosis.
Li Y; Liang L; Zhang CY
Anal Chem; 2013 Dec; 85(23):11174-9. PubMed ID: 24215456
[TBL] [Abstract][Full Text] [Related]
7. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
Cheng G
Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
Gao W; Liu L; Lu X; Shu Y
Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
[No Abstract] [Full Text] [Related]
9. Circulating microRNAs: macro-utility as markers of prostate cancer?
Selth LA; Tilley WD; Butler LM
Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
[TBL] [Abstract][Full Text] [Related]
10. microRNA and Lung Cancer.
Del Vescovo V; Denti MA
Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication of microrna for lung cancer.
Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA as a new factor in lung and esophageal cancer.
Billeter AT; Barnett RE; Druen D; Polk HC; van Berkel VH
Semin Thorac Cardiovasc Surg; 2012; 24(3):155-65. PubMed ID: 23200070
[TBL] [Abstract][Full Text] [Related]
16. [MicroRNAs in diagnosis and prognosis in lung cancer].
Avila-Moreno F; Urrea F; Ortiz-Quintero B
Rev Invest Clin; 2011; 63(5):516-35. PubMed ID: 22468482
[TBL] [Abstract][Full Text] [Related]
17. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer.
Cho WC
Expert Rev Mol Diagn; 2011 Nov; 11(8):763-6. PubMed ID: 22022936
[No Abstract] [Full Text] [Related]
18. A review of expression profiling of circulating microRNAs in men with prostate cancer.
Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
